Today’s Research Reports on Trending Tickers: Heat Biologics and ImmunoGen

NEW YORK, NY / ACCESSWIRE / February 1, 2018 / U.S. markets rallied late Wednesday to close in the green, with the Dow Jones and S&P 500 posting their best monthly gain since March 2016. The Dow Jones Industrial Average gained 0.28 percent to close at 26,149.39, for a monthly gain of 5.79 percent, while the S&P 500 Index rose 0.05 percent to close at 2,823.81, for a monthly gain of 5.62 percent. The Nasdaq Composite Index increased 0.12 percent to close at 7,411.48, for a monthly gain of 7.36 percent. The Nasdaq’s monthly rise was the most since October 2015. On Wednesday, the Federal Reserve stated that it expects inflation “up this year and to stabilize” around its 2 percent target. An interest rate hike is widely expected to happen at the next Fed meeting in March.

RDI Initiates Coverage on:

Heat Biologics, Inc.
https://rdinvesting.com/news/?ticker=HTBX

ImmunoGen, Inc.
https://rdinvesting.com/news/?ticker=IMGN

Heat Biologics stock jumped 20.14% Wednesday, to close the day at $3.40. The stock recorded a trading volume of 5,033,757 shares, which was above its three months average volume of 96,735 shares. In the last year, Heat Biologics shares have traded in a range of 2.60 – 12.50. The share price has gained 30.77% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $3.72 is below its 200-day moving average of $5.12. Shares of Heat Biologics have fallen roughly 91.12 percent in the past month.

Access RDI’s Heat Biologics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=HTBX

On Wednesday, shares of ImmunoGen recorded a trading volume of 8,786,001 shares, which was above the three months average volume of 2,806,632 shares. The stock ended the day 10.34% higher at 9.18. The share price has gained 302.63% from its 52 week low with a 52 week trading range of 2.28 – 9.54. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $7.26 is greater than its 200-day moving average of $6.56. Shares of ImmunoGen have gained roughly 43.21 percent in the past month.

Access RDI’s ImmunoGen, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IMGN

Our Actionable Research on Heat Biologics, Inc. (NASDAQ:HTBX) and ImmunoGen, Inc. (NASDAQ:IMGN) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 487570